glutamic acid and Chronic Progressive Multiple Sclerosis

glutamic acid has been researched along with Chronic Progressive Multiple Sclerosis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	3 (37.50)	24.3611
2020's	2 (25.00)	2.80

Authors

Authors	Studies
Castañares, C; Cristiano, E; Lopez, PH; Pappolla, A; Patrucco, L; Rojas, JI; Sánchez, F; Varela, L	1
C, B; C, F; Cp, Z; G, C; G, DC; M, C; M, F; M, G; M, R; M, S; R, F; S, A	1
Abdel-Aziz, K; Altmann, DR; Ciccarelli, O; Day, BL; Peters, AL; Schneider, T; Solanky, BS; Thompson, AJ; Wheeler-Kingshott, CA; Yiannakas, MC	1
Freedman, MS; Kolind, SH; Li, DK; MacMillan, EL; Oger, J; Tam, R; Traboulsee, AL; Vavasour, IM; Zhao, Y	1
Baranovičová, E; Bittšanský, M; Čierny, D; Hnilicová, P; Kantorová, E; Kurča, E; Nosáľ, V; Poláček, H; Sivák, Š; Zeleňák, K	1
Chard, DT; Ingle, GT; McLean, MA; Miller, DH; Ramió-Torrentà, L; Sastre-Garriga, J; Thompson, AJ	1
Greer, JM; Pender, MP	1
Bisaga, GN; Odinak, MM; Pozdniakov, AV; Tiutin, LA	1

Trials

1 trial(s) available for glutamic acid and Chronic Progressive Multiple Sclerosis

Article	Year
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Archives of neurology, 2005, Volume: 62, Issue:4 Topics: Adult; Age of Onset; Aged; Aspartic Acid; Biomarkers; Case-Control Studies; Cerebral Cortex; Choline; Disability Evaluation; Disease Progression; Female; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Fibers, Myelinated; Neurons; Neuropil; Phosphocreatine; Predictive Value of Tests; Reference Values; Statistics as Topic	2005

Article

Year

Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.

Archives of neurology, 2005, Volume: 62, Issue:4

Topics: Adult; Age of Onset; Aged; Aspartic Acid; Biomarkers; Case-Control Studies; Cerebral Cortex; Choline; Disability Evaluation; Disease Progression; Female; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Fibers, Myelinated; Neurons; Neuropil; Phosphocreatine; Predictive Value of Tests; Reference Values; Statistics as Topic

2005

Other Studies

7 other study(ies) available for glutamic acid and Chronic Progressive Multiple Sclerosis

Article	Year
[Prognostic value of cerebrospinal fluid glutamate in multiple sclerosis]. Medicina, 2021, Volume: 81, Issue:5 Topics: Glutamic Acid; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prognosis	2021
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis. Multiple sclerosis and related disorders, 2020, Volume: 41 Topics: Adult; Blood Platelets; Female; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Inflammation; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells	2020
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 6 Topics: Adolescent; Adult; Aged; Aspartic Acid; Atrophy; Brain; Case-Control Studies; Cervical Cord; Disability Evaluation; Early Diagnosis; Female; Glutamic Acid; Glutamine; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Nerve Degeneration; Proton Magnetic Resonance Spectroscopy; Spinal Cord; White Matter; Young Adult	2015
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years. Multiple sclerosis (Houndmills, Basingstoke, England), 2016, Volume: 22, Issue:1 Topics: Adult; Aged; Biomarkers; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Time Factors	2016
Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. Neurological research, 2017, Volume: 39, Issue:4 Topics: Adult; Aging; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectional Studies; Depression; Disability Evaluation; Fatigue; Female; Glutamic Acid; Humans; Hypothalamus; Inositol; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Severity of Illness Index	2017
The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:5 Topics: Alleles; Binding Sites; Disease Progression; Genotype; Glutamic Acid; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Multiple Sclerosis, Chronic Progressive	2005
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2001, Volume: 101, Issue:4 Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phosphocreatine; Severity of Illness Index	2001